Improvements in the NRI, IDI, and c-statistics revealed that the AST-to-ALT ratio could have clinical importance in screening for the risk of metabolic syndrome, beyond the information suggested by traditional risk factors. This evidence concerns the gene GPT and metabolic syndrome.